PPIST11176

Protein Information
Protein_Chain A; D; G/B; E; H
Protein_Sequence GEDIVADHVASYGVNLYQSYGPSGQYSHEFDGDEEFYVDLERKETVWQLPLFRRFRRFDPQFALTNIAVLKHNLNCVIKRSNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHSVTEGVSETSFLSKSDHSFFKISYLTFLPSDDEIYDCKVEHWGLDEPLLKHWEPE/SPEDFVYQFKGMCYFTNGTERVRLVTRYIYNREEYARFDSDVGVYRAVTPLGPPAAEYWNSQKEVLERTRAELDTVCRHNYQLELRTTLQRRVEPTVTISPSRTEALNHHNLLVCSVTDFYPAQIKVRWFRNDQEETTGVVSTPLIRNGDWTFQILVMLEMTPQRGDVYTCHVEHPSLQNPIIVEWRAQ
Peptide Information
Peptide_Chain C; F; I
Peptide_Sequence GVEELYLVAGEEGCGG
Peptide_Length 16
Non-standard residues No
Interaction Information
PDB_ID 5UJT
Method X-RAY DIFFRACTION
Resolution 1.94 angstrom
Structure
Protein-peptide residue interaction
Residues
Acidic
Polar
Basic
Aliphatic
Aromatic
Interactions
HBond
WaterBridge
Hydrophobic
SaltBridge
PiStack
PiCation
Halogen
Metal
Interaction_xlsx Download interaction table (.xlsx)
Reference Information
Title C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes.
Release_Year 2018
PMID 29255035
DOI 10.1073/pnas.1716527115